autologous CD7-CAR T cells / Beijing Boren Hospital 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
autologous CD7-CAR T cells / Beijing Boren Hospital
NCT04840875: Phase I Clinical Trial of Autologous CD7-CAR T Cells in the Treatment of High-risk Acute T-cell Leukemia / Lymphoma

Recruiting
1
20
RoW
chimeric antigen receptor T cell treatment
Beijing Boren Hospital
T Cell Lymphoma, T-cell Leukemia
04/23
04/25
ChiCTR2100042807: A single-center, open, non-randomized, single-arm clinical trial of autologous CD7-CAR T cells in the treatment of refractory/relapsed CD7-positive lymphoma

Recruiting
N/A
30
 
Reinfusion cell
Beijing Boren Hospital; Beijing Boren Hospital, Self-funded
Refractory/relapsed CD7 positive lymphoma
 
 

Download Options